Artigo de periodico

Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)

• Authors:
  • Oliveira, Milena Locci de
  • Rocha, Adriana
  • Nardotto, Glauco Henrique Balthazar
  • Pippa, Leandro Francisco
  • Simões, Belinda Pinto
  • Lanchote, Vera Lucia
• USP affiliated authors: ROCHA, ADRIANA - FCFRP ; SIMOES, BELINDA PINTO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; OLIVEIRA, MILENA LOCCI DE - FCFRP ; NARDOTTO, GLAUCO HENRIQUE BALTHAZAR - FCFRP ; PIPPA, LEANDRO FRANCISCO - FCFRP
• Unidades: FCFRP; FMRP
• DOI: 10.1016/j.jpba.2020.113576
• Subjects: LEUCEMIA MIELOIDE AGUDA; ANTINEOPLÁSICOS; METABÓLITOS; FARMACOCINÉTICA
• Keywords: Daunorubicin; LC–MS/MS; Pharmacokinetics; Metabolite; Acute myeloid leukemia; Biological fluid
• Agências de fomento:
  • Financiamento CAPES
  • Financiamento CNPq
• Language: Inglês
• Imprenta:
  • Publisher place: Amsterdam
  • Date published: 2020
• Source:
  • Título: Journal of Pharmaceutical and Biomedical Analysis
  • ISSN: 0731-7085
  • Volume/Número/Paginação/Ano: v. 191, art. 113576, p. 1-8, 2020

Informações sobre o DOI: 10.1016/j.jpba.2020.113576 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

Download do texto completo

Tipo	Nome	Link
	003032856.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 27 dez. 2025.

• APA

  Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576

• NLM

  Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576

• Vancouver

  Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Clinical treatment for hepatitis C reverses CYP2C19 inhibition
• Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio
• No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients
• Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis
• Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers
• Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin
• Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study
• Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients
• Esquema de amostragem esparsa para avaliar a farmacocinética da daunorrubicina e seu metabólito daunorrubicinol em pacientes adultos e pediátricos diagnosticados com leucemia mieloide aguda
• Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers